Were PCSK9 Inhibitors Overhyped?

Video

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses access to cholesterol-lowering PCSK9 inhibitors and whether the hype regarding the impact of these medications was overblown.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses access to cholesterol-lowering PCSK9 inhibitors and whether the hype regarding the impact of these medications was overblown.

Recent Videos
Group of doctors and nurses standing together in different poses.
Alzheimer and dementia clock drawing cognitive test -- Image credit: Jovana Milanko/Stocksy | stock.adobe.com
Oncology, MARIPOSA Trial, Lung Cancer | Image Credit: Konstantin Yuganov - stock.adobe.com
Pharmacy Students, TikTok, social media, interactive learning | Image Credit: peopleimages.com - stock.adobe.com
Public Health Matters podcast logo
Virtual Reality for Pharmacy School | Image Credit: toxicoz - stock.adobe.com
Non Small Cell Lung Cancer (NSCLC) in the lung tissue – closeup view 3d illustration
Covid-19 Vaccine New Variant 2024-2025 | Image Credit: New Africa - stock.adobe.com
Pharmacy students, university, assignment, tiktok | Image Credit: .shock - stock.adobe.com
Pharmacy Students in Lab, TikTok | Image Credit: D Lahoud/peopleimages.com - adobe.stock.com
Related Content
FTC building in Washington DC.

FTC Sues Major Pharmacy Benefit Managers Over Price of Insulin

Luke Halpern, Assistant Editor
September 20th 2024
Article
Public Health Matters podcast logo

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

September 19th 2024
Podcast
Pharmacist working in a pharmacy -- Image credit: lubero | stock.adobe.com

Enhancing Patient Outcomes: The Role of Integrated Health System Specialty Pharmacies

Brad Myers, PharmD, MBA
September 19th 2024
Article
Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development

Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development

Ashley Gallagher, Associate Editor
August 23rd 2024
Podcast
Pharmacy, FDA Approval, Eosinophilic Granulomatosis With Polyangiitis | Image Credit: rh2010 - stock.adobe.com

FDA Approves Benralizumab for Eosinophilic Granulomatosis With Polyangiitis

Ashley Gallagher, Associate Editor
September 18th 2024
Article
Diabetes, New CGM, Continuous Glucose Monitoring, FDA Clearance | Image Credit: Minerva Studio - stock.adobe.com

FDA Clears First 1-Year Continuous Glucose Monitoring System for Diabetes

Ashley Gallagher, Associate Editor
September 17th 2024
Article